Interleukin-21 engineering enhances CD19-specific CAR-NK cell activity against B-cell lymphoma via enriched metabolic pathways
Bailin He(Dalian Medical University), Na Xu(Agricultural Genomics Institute at Shenzhen), Hongsheng Zhou(Nanfang Hospital), Jiaxu Wu(Southern Medical University), Shikai Deng(Southern Medical University), Qing Zeng(Southern Medical University), Shiqiu Qiu(First Affiliated Hospital of Guangdong Pharmaceutical University), Hong Chen(North West Agriculture and Forestry University), Xuan Li(Nanfang Hospital), Xiaoli Liu(Xizang Minzu University), Cong Wang(Southern Medical University), Qiusui Mai(Sun Yat-sen University), Chengyao Li(Guangzhou Electronic Technology (China)), Zihong Cai(Nanfang Hospital), Qifa Liu(Nanfang Hospital)
Cited by 6
Related Papers
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
Circular RNA profiling reveals an abundant circLMO7 that regulates myoblasts differentiation and survival by sponging miR-378a-3p
|Cell Death and Disease|2017|247
Lipids and lipid metabolism in cellular senescence: Emerging targets for age-related diseases
|Ageing Research Reviews|2024|150
Circular RNA TTN Acts As a miR-432 Sponge to Facilitate Proliferation and Differentiation of Myoblasts via the IGF2/PI3K/AKT Signaling Pathway
|Molecular Therapy — Nucleic Acids|2019|103